Form 13-F position report

ASPIRA WOMENS HEALTH INC

Reported by Cannell & Co

AWH CUSIP 04537Y109 Manager CIK 0000016972

Reported 117,200 shares, unchanged from the prior quarter.

Reported value -16.7%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value 0.02% This manager · Q2 2021
Shares 117,200 Quarter-end amount reported
Reported value $659,000 Fair value at quarter end
Consecutive quarters held 5 Through Q2 2021

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2020-06-30 450000
2020-09-30 362000
2020-12-31 786000
2021-03-31 791000
2021-06-30 659000
2021-09-30 381000
2021-12-31 197000
2022-03-31 116000
2022-06-30 65000
2022-09-30 41000
2022-12-31 36985
2023-03-31 40699
2023-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

13 quarters
Quarterly reported position history for ASPIRA WOMENS HEALTH INC held by Cannell & Co.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2023 Reduced 0 -111,200 (-100.0%) 0 $0 2023-08-09
Q1 2023 Unchanged 111,200 0 (0.0%) < 0.01% $40,699 2023-05-08
Q4 2022 Unchanged 111,200 0 (0.0%) < 0.01% $36,985 2023-02-03
Q3 2022 Unchanged 111,200 0 (0.0%) < 0.01% $41,000 2022-11-02
Q2 2022 Unchanged 111,200 0 (0.0%) < 0.01% $65,000 2022-08-08
Q1 2022 Unchanged 111,200 0 (0.0%) < 0.01% $116,000 2022-05-10
Q4 2021 Reduced 111,200 -6,000 (-5.1%) < 0.01% $197,000 2022-02-09
Q3 2021 Unchanged 117,200 0 (0.0%) 0.01% $381,000 2021-11-10
Q2 2021 Unchanged 117,200 0 (0.0%) 0.02% $659,000 2021-08-09
Q1 2021 Unchanged 117,200 0 (0.0%) 0.02% $791,000 2021-05-07
Q4 2020 Unchanged 117,200 0 (0.0%) 0.03% $786,000 2021-02-11
Q3 2020 Unchanged 117,200 0 (0.0%) 0.01% $362,000 2020-11-12
Q2 2020 New 117,200 +117,200 (0.0%) 0.02% $450,000 2020-08-07

Who else reported the position

111 managers reported ASPIRA WOMENS HEALTH INC for Q2 2021.

Managers reporting ASPIRA WOMENS HEALTH INC in Q2 2021.
Manager Activity Shares Change % of reported 13F Reported value Tenure
ORACLE INVESTMENT MANAGEMENT INC Unchanged 8,647,094 0 6.7% $48,597,000 5 qtrs
BlackRock Inc Reduced 4,646,845 -877,658 < 0.01% $26,114,000 5 qtrs
VANGUARD GROUP INC Reduced 2,983,812 -87,801 < 0.01% $16,770,000 5 qtrs
STATE STREET CORPORATION Added 2,237,134 +80,249 < 0.01% $12,573,000 5 qtrs
GEODE CAPITAL MANAGEMENT LLC Reduced 1,163,858 -59,927 < 0.01% $6,540,000 5 qtrs
ACT CAPITAL MANAGEMENT LLC New 1,130,720 +1,130,720 3.27% $6,355,000 1 qtr
NORTHERN TRUST CORPORATION Reduced 723,090 -114,602 < 0.01% $4,063,000 5 qtrs
Greenwich Wealth Management LLC Added 418,087 +319,397 0.2% $2,350,000 5 qtrs
MILLENNIUM MANAGEMENT LLC Added 361,601 +286,116 < 0.01% $2,032,000 2 qtrs
Nuveen Asset Management LLC Reduced 288,592 -43,395 < 0.01% $1,622,000 5 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2021
Filed
August 09, 2021
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
117,200
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.